Conference
Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization
Abstract
Recombinant virus-vectored TB vaccines represent the most promising vaccine platform for boosting the protective immunity mediated by parenteral BCG prime immunization. A major advantage associated with virus-vectored vaccines is that they are potent respiratory mucosa-deliverable vaccines. A recombinant replication-deficient adenoviral (Ad) vector was engineered to express Mycobacterium tuberculosis (M.tb) Ag85A. Single administration of this …
Authors
Xing Z; Lichty BD
Volume
86
Pagination
pp. 211-217
Publisher
Elsevier
Publication Date
May 2006
DOI
10.1016/j.tube.2006.01.017
Conference proceedings
Tuberculosis
Issue
3-4
ISSN
1472-9792